This site uses cookies to store information on your computer. Learn more x


Pharma & Bulk Chemicals

In recent years DSM established a number of partnerships for its Pharma and Bulk Chemicals activities in order to streamline and simplify its core portfolio in Nutrition and Materials. These partnerships were created with a view to ultimately exiting these businesses.
DSM Sinochem Pharmaceuticals' website

DSM Sinochem Pharmaceuticals

DSM Sinochem Pharmaceuticals, a global leader in generic anti-infective molecules, was formed in 2011 as a 50/50 joint venture between DSM and Sinochem.

On 29 June 2018 Bain Capital announced the proposed acquisition of DSM Sinochem Pharmaceuticals. The transaction is expected to be completed in the fourth quarter of 2018, subject to customary regulatory approvals and consultations, and DSM expects to receive approximately €275 million in cash following closing, including repayment of debt and after transaction costs.


In July 2015 DSM formed ChemicaInvest, a new joint venture with CVC Capital Partners. ChemicaInvest is a global leader in the production and supply of caprolactam and the leading European supplier of acrylonitrile and composite resins. DSM owns 35% of ChemicaInvest which has three business units:

Aliancys' website

Aliancys (composite resins)

Aliancys provides quality resins for composites applications in markets including building & infrastructure, industrial, marine & offshore, transportation, relining/CIPP and wind.

AnQore's website

AnQore (acrylonitrile)

In addition to acrylonitrile AnQore also supplies hydrogen cyanide, acetonitrile, sodium cyanide, diaminobutane (DAB) and pyrrolidine (PRD).

Fibrant's website

Fibrant (caprolactam)

Fibrant supplies caprolactam as well as ammonium sulphate, cyclohexanone, oil stripper bottom (OSB) and CO2. On 17 May 2018 the proposed sale of Fibrant to Highsun Holdings Group Ltd. was announced.